Latest filing published 19 Nov 2014 for Vertex Pharmaceuticals INC / MA, €2,951.
Insider track record
No signal scores available.
Megan E. Pace: trading record in brief
All filings by Megan E. Pace on record concern Vertex Pharmaceuticals INC / MA. Over a trading history stretching from 5 February 2013 to 17 November 2014, the count stands at 37 filings.
Every open-market trade on record is a sale: 21 sales worth €8.9M. Besides market trades, the filings include 3 share grants and 13 option exercises. Since January 2014: no purchases and 13 sales on the market.
On 19 November 2014 came the latest disclosure, an open-market sale for €2,951 in Vertex Pharmaceuticals INC / MA. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Megan E. Pace
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33 shares@ US$111.93Common StockSEC:0001209191-14-069991:0
- 20,000 shares@ US$0.01Common StockSEC:0001209191-14-065912:0
- 1,172 shares@ US$38.80Common StockSEC:0001209191-14-060592:0
- 5,625 shares@ US$51.75Common StockSEC:0001209191-14-060592:1
- 3,532 shares@ US$37.86Common StockSEC:0001209191-14-060592:2
- 15,250 shares@ US$48.74Common StockSEC:0001209191-14-060592:3
- 17,157 shares@ US$45.11Common StockSEC:0001209191-14-060592:4
- 6,875 shares@ US$83.36Common StockSEC:0001209191-14-060592:5
- 6,875 shares@ US$77.31Common StockSEC:0001209191-14-060592:6
- 7,576 shares@ US$111.32Common StockSEC:0001209191-14-060592:7
- 21,881 shares@ US$112.21Common StockSEC:0001209191-14-060592:8
- 15,400 shares@ US$113.08Common StockSEC:0001209191-14-060592:9
- 11,629 shares@ US$113.90Common StockSEC:0001209191-14-060592:10
- 7,500 shares@ US$37.29Common StockSEC:0001209191-14-043875:0
- 5,234 shares@ US$38.80Common StockSEC:0001209191-14-043875:1
- 12,734 shares@ US$98.03Common StockSEC:0001209191-14-043875:2
- 347 shares@ US$65.57Common StockSEC:0001209191-14-035067:0
- 22 shares@ US$67.00Common StockSEC:0001209191-14-035067:1
- 500 shares@ US$67.01Common StockSEC:0001209191-14-031519:0
- 400 shares@ US$67.94Common StockSEC:0001209191-14-031519:1
- 100 shares@ US$69.42Common StockSEC:0001209191-14-031519:2
- 14,250 shares@ US$0.01Common StockSEC:0001209191-14-008357:0
- 1,250 shares@ US$85.00Common StockSEC:0001209191-14-004556:0
- 838 shares@ US$75.00Common StockSEC:0001209191-14-002375:0
- 5,083 shares@ US$65.48Common StockSEC:0001209191-13-056699:0
25 of 36 declarations
